Ospedale San Filippo Neri

Roma 00135

0 studies enrolling now · 3 studies all time

What they study most

Antifungal Agents, Breast Cancer, Ulcerative Colitis and Crohn's Disease

Studies at this site

• Entyvio (Vedolizumab) Long Term Safety Study — Completed
• E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast Cancer — Completed
• Screening Anti-Fungal Exposure in Intensive Care Units — Status unconfirmed